Home Cart Sign in  
Chemical Structure| 193746-75-7 Chemical Structure| 193746-75-7

Structure of SB 242235
CAS No.: 193746-75-7

Chemical Structure| 193746-75-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SB-242235 is a potent and selective p38 MAP kinase inhibitor with IC50 of 1.0 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SB 242235

CAS No. :193746-75-7
Formula : C19H20FN5O
M.W : 353.39
SMILES Code : COC1=NC=CC(C2=C(C3=CC=C(F)C=C3)N=CN2C4CCNCC4)=N1
MDL No. :MFCD08690575
InChI Key :PDTYLGXVBIWRIM-UHFFFAOYSA-N
Pubchem ID :9863367

Safety of SB 242235

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Related Pathways of SB 242235

MAPK
TLR

Isoform Comparison

Biological Activity

Description
SB-242235 is a potent inhibitor of p38 MAP kinase, showcasing an IC50 value of 1.0 μM in primary human chondrocytes. Its ability to dose-dependently suppress the activation of MAPKAP K2 in human chondrocytes stimulated by IL-1β, with the same IC50, highlights its efficacy in inflammatory settings[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.83mL

0.57mL

0.28mL

14.15mL

2.83mL

1.41mL

28.30mL

5.66mL

2.83mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories